Spots Global Cancer Trial Database for unspecified adult solid tumor, protocol specific
Every month we try and update this database with for unspecified adult solid tumor, protocol specific cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors | NCT00390000 | Unspecified Adu... | vatalanib pemetrexed diso... pharmacological... ultrasound imag... | 18 Years - | Mayo Clinic | |
| GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy | NCT01147029 | Unspecified Adu... | angiogenesis in... laboratory biom... pharmacological... dynamic contras... | 18 Years - | Cancer Research UK | |
| Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors | NCT00004923 | Unspecified Adu... | docetaxel irinotecan hydr... | 18 Years - | Yale University | |
| Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein | NCT00964275 | Thromboembolism Unspecified Adu... | diagnostic proc... fludeoxyglucose... | 18 Years - | University Hospital, Brest | |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | NCT00019708 | Extranodal Marg... Nodal Marginal ... Non-Hodgkin Lym... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Margi... Recurrent Small... Splenic Margina... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Unspecified Adu... | tanespimycin | 19 Years - | National Cancer Institute (NCI) | |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants | NCT00992303 | Unspecified Adu... | biologic sample... medical chart r... questionnaire a... | 18 Years - | University of Texas Southwestern Medical Center | |
| Study of Hair Samples From Patients With Cancer | NCT00899691 | Unspecified Adu... | protein express... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
| SU6668 in Treating Patients With Advanced Solid Tumors | NCT00024206 | Unspecified Adu... | orantinib laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors | NCT00014248 | Cachexia Unspecified Adu... | adenosine triph... quality-of-life... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Endostatin in Treating Patients With Advanced Solid Tumors | NCT00004229 | Unspecified Adu... | recombinant hum... | 18 Years - | National Cancer Institute (NCI) | |
| VNP20009 in Treating Patients With Advanced Solid Tumors | NCT00006254 | Unspecified Adu... | salmonella VNP2... | 18 Years - | National Cancer Institute (NCI) | |
| Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery | NCT01537107 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IV Pancre... Unspecified Adu... | vismodegib sirolimus positron emissi... computed tomogr... pharmacological... laboratory biom... fludeoxyglucose... | 18 Years - | Mayo Clinic | |
| MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors | NCT00004886 | Unspecified Adu... | docetaxel dofequidar fuma... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Bevacizumab in Treating Patients With Advanced Solid Tumors | NCT00416637 | Unspecified Adu... | Bevacizumab (Av... | 18 Years - | Duke University | |
| Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C | NCT00040729 | Unspecified Adu... | mutation analys... | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| Carboxyamidotriazole and Ketoconazole in Treating Patients With Advanced Cancers | NCT00003249 | Unspecified Adu... | carboxyamidotri... chemotherapy ketoconazole | 18 Years - | National Cancer Institute (NCI) | |
| Levetiracetam in Treating Patients With Seizures Caused by Brain Metastases | NCT00415376 | Brain and Centr... Seizure Unspecified Adu... | levetiracetam quality-of-life... | 18 Years - | Northwestern University | |
| Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid Tumor | NCT00005839 | Unspecified Adu... | capecitabine oxaliplatin | 18 Years - | City of Hope Medical Center | |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | NCT00372736 | Unspecified Adu... | AEG35156 docetaxel protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| NGR-TNF in Treating Patients With Advanced Solid Tumors | NCT00098943 | Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu... | CNGRC peptide-T... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | NCT02048943 | Duct Cell Adeno... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... paclitaxel albu... pharmacological... laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| Study of Decision Making in Patients Participating in Phase I Clinical Trials | NCT00054223 | Psychosocial Ef... Unspecified Adu... | psychosocial as... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Gefitinib and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT00039390 | Unspecified Adu... | capecitabine gefitinib pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Daptomycin in Treating Neutropenia and Fever in Patients With Cancer | NCT00335478 | Fever Sweating Hot Flashes Infection Neutropenia Unspecified Adu... | Daptomycin | 18 Years - 99 Years | OHSU Knight Cancer Institute | |
| Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00238225 | Unspecified Adu... | calcitriol dexamethasone ketoconazole | 18 Years - | Roswell Park Cancer Institute | |
| Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant | NCT00003894 | Graft Versus Ho... Unspecified Adu... Unspecified Chi... | thalidomide | 3 Years - | Roswell Park Cancer Institute | |
| Buspirone in Reducing Shortness of Breath in Patients With Cancer | NCT00053846 | Dyspnea Pulmonary Compl... Unspecified Adu... | buspirone hydro... Placebo | 18 Years - 120 Years | University of Rochester | |
| Bupropion and Counseling With or Without Contingency Management to Enhance Smoking Cessation in Treating Cancer Survivors Who Continue to Smoke | NCT00079469 | Cancer Survivor Unspecified Adu... | smoking cessati... bupropion hydro... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index | NCT00128570 | Unspecified Adu... | behavioral diet... educational int... internet-based ... preventative di... evaluation of c... | 18 Years - 63 Years | National Cancer Institute (NCI) | |
| Stereotactic Radiosurgery in Treating Patients With Brain Metastases | NCT00811655 | Metastatic Canc... Unspecified Adu... | therapeutic con... stereotactic ra... | 18 Years - | Duke University | |
| LY293111 in Treating Patients With Advanced Solid Tumors | NCT00006375 | Unspecified Adu... | LY293111 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors | NCT00352131 | Non-colorectal ... Pancreatic Canc... | HuC242-DM4 | 18 Years - | ImmunoGen, Inc. | |
| Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | NCT02013492 | Male Breast Can... Recurrent Melan... Stage IV Breast... Stage IV Melano... Stage IV Ovaria... Stage IV Ovaria... Unspecified Adu... Hepatocellular ... | propranolol hyd... Correlative Stu... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma | NCT00101244 | Adult Grade III... Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Unspecified Adu... Waldenström Mac... | ispinesib laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan Plus Mitomycin in Treating Patients With Advanced Solid Tumors | NCT00003710 | Unspecified Adu... | irinotecan hydr... mitomycin C | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| R115777 in Treating Patients With Advanced Solid Tumors | NCT00025454 | Unspecified Adu... | tipifarnib | 18 Years - | City of Hope Medical Center | |
| Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | NCT00138177 | Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... Unspecified Adu... | oxaliplatin leucovorin calc... vorinostat fluorouracil | 18 Years - | National Cancer Institute (NCI) | |
| Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors | NCT00008086 | Brain and Centr... Unspecified Adu... | calcitriol carboplatin | 18 Years - | University of Pittsburgh | |
| Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | NCT00390429 | Lung Cancer Unspecified Adu... | docetaxel erlotinib hydro... | 18 Years - | University of California, Davis | |
| CCI-779 in Treating Patients With Advanced Solid Tumors | NCT00003712 | Brain and Centr... Metastatic Canc... Unspecified Adu... | temsirolimus | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Analysis of Dendritic Phenotype and Function of Patients Receiving VEGF-Trap on VGFT-ST-0202 | NCT00896662 | Lymphoma Solid Tumor | immunologic tec... laboratory biom... pharmacological... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Oxaliplatin in Treating Patients With Advanced Cancer Plus Liver Dysfunction | NCT00005077 | Unspecified Adu... | oxaliplatin | 18 Years - | City of Hope Medical Center | |
| Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | NCT00072436 | Unspecified Adu... | gemcitabine hyd... alvocidib pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| PR104 and G-CSF in Treating Patients With Solid Tumors | NCT00616213 | Unspecified Adu... | filgrastim PR104 F-18-fluoromiso... | 18 Years - | Proacta, Incorporated | |
| Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00112476 | Recurrent Melan... Recurrent Renal... Stage IV Melano... Stage IV Renal ... Unspecified Adu... | bryostatin 1 temsirolimus | 18 Years - | National Cancer Institute (NCI) | |
| Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00387504 | Unspecified Adu... | fenretinide pharmacological... | 18 Years - | California Cancer Consortium | |
| Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors | NCT00086983 | Unspecified Adu... | becatecarin oxaliplatin pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | NCT00007917 | Unspecified Adu... | alvocidib gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor | NCT00004243 | Unspecified Adu... | docetaxel oxaliplatin | 18 Years - | City of Hope Medical Center | |
| Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | NCT00003207 | Sarcoma Unspecified Adu... | pegylated lipos... PSC 833 | 18 Years - | Washington University School of Medicine | |
| Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | NCT00009815 | Unspecified Adu... | etoposide leucovorin calc... tegafur-uracil | 18 Years - | University of Pittsburgh | |
| Stress Management Training in Patients Undergoing Radiation Therapy for Cancer | NCT00057733 | Anxiety Disorde... Depression Unspecified Adu... | psychosocial as... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | NCT01217450 | Recurrent Colon... Recurrent Recta... Stage IVA Colon... Stage IVA Recta... Stage IVB Colon... Stage IVB Recta... Unspecified Adu... | selumetinib cetuximab laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors | NCT01233505 | Adenocarcinoma ... Adenocarcinoma ... BRCA1 Mutation ... BRCA2 Mutation ... Ovarian Mucinou... Recurrent Breas... Recurrent Colon... Recurrent Gastr... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Colon ... Stage IV Gastri... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Unspecified Adu... | veliparib capecitabine oxaliplatin pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Drugs to Reduce the Side Effects of Chemotherapy | NCT00003213 | Nausea and Vomi... Unspecified Adu... | dexamethasone granisetron hyd... metoclopramide ... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma | NCT00512798 | Brain and Centr... Melanoma Solid Tumor | PS-341 (VELCADE... temozolomide immunoenzyme te... PS-341 (VELCADE... Temozolomide | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer | NCT02088775 | Adult Primary H... Advanced Adult ... Metastatic Extr... Recurrent Adult... Recurrent Extra... Stage D Adult P... Unspecified Adu... | PET scan CT Scan hepatic artery ... | 18 Years - | Fox Chase Cancer Center | |
| Buspirone in Reducing Shortness of Breath in Patients With Cancer | NCT00053846 | Dyspnea Pulmonary Compl... Unspecified Adu... | buspirone hydro... Placebo | 18 Years - 120 Years | University of Rochester | |
| SORAVE - Sorafenib and Everolimus in Solid Tumors | NCT00933777 | Unspecified Adu... Non-Small Cell ... | Combination of ... | 18 Years - | University of Cologne | |
| Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia | NCT01159301 | Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Blastic Phase C... Recurrent Adult... Unspecified Adu... | entinostat sorafenib tosyl... pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors | NCT00074022 | Recurrent Non-s... Recurrent Prost... Stage III Prost... Stage IIIA Non-... Stage IIIB Non-... Stage IV Non-sm... Stage IV Prosta... Unspecified Adu... | GTI-2040 docetaxel laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations | NCT00169312 | Unspecified Adu... | behavioral diet... dietary interve... educational int... internet-based ... preventative di... evaluation of c... | 21 Years - 65 Years | National Cancer Institute (NCI) | |
| Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity | NCT00825201 | Ovarian Cancer Peritoneal Cavi... Unspecified Adu... | paclitaxel albu... liquid chromato... mass spectromet... pharmacological... laboratory biom... | 19 Years - | City of Hope Medical Center | |
| Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function | NCT00118170 | Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Mult... Splenic Margina... Stage II Multip... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Adult... Stage III Grade... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Multi... Stage III Small... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Adult ... Stage IV Grade ... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Unspecified Adu... Waldenström Mac... | sorafenib tosyl... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Solid Tumors | NCT00009932 | Unspecified Adu... | cisplatin fenretinide paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors | NCT00047047 | Unspecified Adu... | gemcitabine hyd... tanespimycin cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy | NCT00052221 | Fatigue Unspecified Adu... | Epoetin alfa Placebo | 18 Years - | M.D. Anderson Cancer Center | |
| Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma | NCT00276536 | Breast Cancer Kidney Cancer Lymphoma Melanoma Multiple Myelom... Sarcoma Unspecified Adu... | recombinant int... IFN | 18 Years - 120 Years | The Cleveland Clinic | |
| Chemotherapy in Treating Patients With Advanced Solid Tumors | NCT00003708 | Unspecified Adu... | temozolomide | 18 Years - | The University of Texas Health Science Center at San Antonio | |
| Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors | NCT00892385 | Unspecified Adu... | Methoxyamine Temozolomide | 18 Years - | Case Comprehensive Cancer Center | |
| Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer | NCT00296062 | Colorectal Canc... Unspecified Adu... | bevacizumab capecitabine irinotecan hydr... oxaliplatin | 18 Years - | Case Comprehensive Cancer Center | |
| Measuring Biomarker Response to AMP-514 in Blood Samples From Patients With Solid Tumors Undergoing Radiotherapy | NCT02153151 | Unspecified Adu... | Cytology specim... Laboratory biom... | 18 Years - | Thomas Jefferson University | |
| Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers | NCT01497392 | Adenocarcinoma ... Stage III Pancr... Stage IV Pancre... Unspecified Adu... | dovitinib lacta... gemcitabine hyd... capecitabine laboratory biom... enzyme-linked i... pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer | NCT00020657 | Nausea and Vomi... Unspecified Adu... | dolasetron mesy... granisetron hyd... ondansetron prochlorperazin... quality-of-life... | 18 Years - 120 Years | University of Rochester | |
| Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors | NCT02215928 | Unspecified Adu... | mutation analys... cytology specim... laboratory biom... | 18 Years - | Stanford University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
